PBGENE-LLY3

N/A

Report date: 2025/03/07 11:49:13

Base Information

Drug NamePBGENE-LLY3
Drug Alias NamePBGENE-LLY3PBGENE-CNS
ClassificationCell and gene therapy > Gene therapy > Gene editing
Mechanisms of ActionGene expression modulators
TargetsUpdating
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrecision Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrecision Biosciences Inc
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A